Advertisement

Pharmacy

The antibiotic amoxicillin is in short supply among at least three drugmakers, according to the American Society of Health-System Pharmacists and Bloomberg. 

Advertisement

When the FDA advised vaccine-makers in late June to engineer their boosters to target subvariants BA.4 and BA.5, at the time the "sister variants" accounted for a slight majority of infections. Four months later, new mutations BQ.1 and BQ.1.1 have…

Advertisement